4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and rosiglitazone

Research

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Gege, C; Hoffmann, T; Schlüter, T	1
Askari, HB; Beauchamp, DA; Cheung, W; Gaul, MD; Geisler, JG; Huang, H; Kasturi, J; Liu, J; Patch, RJ; Patel, S; Player, MR; Rentzeperis, D; Towers, M; Xu, G; Zhao, BP	1

3 other study(ies) available for 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and rosiglitazone

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt. Bioorganic & medicinal chemistry letters, 2014, Nov-15, Volume: 24, Issue:22 Topics: Benzeneacetamides; Drug Inverse Agonism; Fluorescence Resonance Energy Transfer; Humans; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 2; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Th17 Cells; Thiazoles; Tretinoin	2014
Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents. European journal of medicinal chemistry, 2017, Sep-29, Volume: 138 Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; ERRalpha Estrogen-Related Receptor; Hypoglycemic Agents; Indazoles; Ligands; Male; Mice; Mice, Obese; Molecular Structure; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Estrogen; Structure-Activity Relationship	2017